What are the recommended oral and intravenous doses of acyclovir, valacyclovir, and famciclovir for treating varicella (chickenpox) and herpes zoster (shingles), and what postpartum counseling regarding varicella and zoster vaccination is indicated despite prior natural infection?

Antiviral Dosing for Varicella and Zoster Infections

Treatment Doses for Varicella (Chickenpox)

For varicella treatment, oral acyclovir 800 mg four times daily for 5 days is the standard regimen in adults and children over 40 kg, while children 2 years and older receive 20 mg/kg per dose four times daily (maximum 80 mg/kg/day) for 5 days. 1

• Therapy should be initiated within 24 hours of rash onset for maximum benefit 1, 2
• Intravenous acyclovir (10-15 mg/kg or 500 mg/m² IV every 8 hours for 5-10 days) is indicated for immunocompromised patients, severe complications like pneumonitis, or neonates 3, 2
• For pregnant women with significant varicella infection (e.g., pneumonitis), oral acyclovir 800 mg 5 times daily is recommended, with IV acyclovir considered for severe complications 2

Treatment Doses for Herpes Zoster (Shingles)

For herpes zoster, oral acyclovir 800 mg five times daily for 7-10 days is the FDA-approved regimen, though valacyclovir 1000 mg three times daily for 7 days offers superior pain resolution with simpler dosing. 1, 4

Oral Antiviral Options:

• Acyclovir: 800 mg every 4 hours (5 times daily) for 7-10 days 1
• Valacyclovir: 1000 mg three times daily for 7 days—significantly accelerates pain resolution compared to acyclovir (median 38 days vs 51 days) and reduces postherpetic neuralgia duration 4
• Famciclovir: 500 mg twice daily for 7 days—comparable efficacy to acyclovir with more convenient dosing 5

Intravenous Therapy:

• IV acyclovir: 500 mg/m² or 10 mg/kg every 8 hours for 7 days in immunocompromised patients 3, 6
• IV therapy reduces cutaneous and visceral dissemination in immunocompromised hosts 3

Renal Dose Adjustments

All acyclovir dosing must be adjusted for renal impairment to prevent neurotoxicity and crystalline nephropathy. 1

• For CrCl 10-25 mL/min with 800 mg dosing: reduce to 800 mg every 8 hours 1
• For CrCl 0-10 mL/min with 800 mg dosing: reduce to 800 mg every 12 hours 1
• Hemodialysis patients require an additional dose after each dialysis session 1
• Adequate hydration and urine flow must be maintained, especially with high-dose therapy 6

---

Postpartum Vaccination Counseling

Why Vaccination After Natural Infection Matters

Postpartum varicella vaccination is recommended for all non-immune women despite prior natural infection because immunity status may be uncertain, antibody levels can wane over time, and vaccination provides consistent protection against severe disease and transmission to vulnerable contacts. 2, 7

Key Counseling Points for Varicella Vaccination:

• Routine antenatal screening should document immunity status through history, vaccination records, or VZV IgG serology 2
• Women without documented evidence of immunity should receive varicella vaccine postpartum before hospital discharge 7, 2
• Two doses are required: The second dose should be administered 4-8 weeks after the first dose for persons ≥13 years 7
• Vaccination should be delayed 5 months after VZIG administration if given during pregnancy 7

Why Natural Infection Doesn't Eliminate Vaccination Need:

1. Immunity verification is often unreliable: Patient recall of childhood varicella is imperfect, and mild cases may be forgotten or misidentified 2
2. Serologic confirmation is essential: Without laboratory documentation, immunity status remains uncertain 2
3. Protection of future pregnancies: Ensures immunity before subsequent conceptions, preventing congenital varicella syndrome risk 2
4. Healthcare worker protection: If the woman works in healthcare or childcare settings, documented immunity is mandatory 7

Zoster Vaccination Considerations:

Zoster vaccination is not routinely discussed postpartum but becomes relevant at age ≥50 years, as natural varicella infection does not prevent herpes zoster—in fact, it is a prerequisite for zoster development. 8

• Approximately 30% of allogeneic transplant recipients with prior varicella develop zoster without prophylaxis 8
• Natural immunity prevents reinfection with exogenous varicella but does not prevent endogenous reactivation as zoster 8
• Zoster vaccines (recombinant or live-attenuated) boost cell-mediated immunity to reduce reactivation risk in older adults

Common Pitfalls to Avoid:

• Never assume immunity based on patient history alone—always obtain serologic confirmation or vaccination records 2
• Do not administer varicella vaccine during pregnancy—it is a live-attenuated vaccine contraindicated in pregnancy, though inadvertent vaccination does not warrant termination 2
• Do not delay postpartum vaccination—administer before discharge to ensure compliance 7
• Remember that having had chickenpox does not protect against shingles—this is the most common misconception requiring clarification 8